ClearOne is trading 10.1% down at $4.70, with no confirmed company-specific catalyst identified for the October 1 decline. - ClearOne’s investor-relations page lists its July 2 merger announcement as its latest release. - The Cortigent transaction’s anticipated October closing is background, not a confirmed explanation for the decline. - Supplied market context shows only modest index declines; available evidence does not establish a direct market or company catalyst.